Search Results - "Gormley, Glenn"

Refine Results
  1. 1

    The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia by Lepor, Herbert, Williford, William O, Barry, Michael J, Brawer, Michael K, Dixon, Christopher M, Gormley, Glenn, Haakenson, Clair, Machi, Madeline, Narayan, Perinchery, Padley, Robert J

    Published in The New England journal of medicine (22-08-1996)
    “…Benign prostatic hyperplasia is a proliferative process that involves both the stromal and epithelial elements of the prostate. 1 , 2 Its clinical…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Comparison of Alendronate and Intranasal Calcitonin for Treatment of Osteoporosis in Postmenopausal Women by Downs, Robert W, Bell, Norman H, Ettinger, Mark P, Walsh, Brian W, Favus, Murray J, Mako, Barbara, Wang, Lixia, Smith, Mary E, Gormley, Glenn J, Melton, Mary E

    Published in Obstetrical & gynecological survey (01-10-2000)
    “…Both alendronate and calcitonin, the latter administered intranasally, reportedly increase bone mineral density (BMD) and reduce bone turnover, but alendronate…”
    Get full text
    Journal Article
  7. 7

    Finasteride for Benign Prostatic Hyperplasia by Geller, D. Michael, DuBeau, Catherine E, Blumenstein, Brent A, Gormley, Glenn J, Stoner, Elizabeth, Slater, Eve E

    Published in The New England journal of medicine (11-02-1993)
    “…To the Editor: In my primary care internal medicine practice, the most common symptoms that I hear of from men with prostatic hyperplasia are nocturia and…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women by DOWNS, R. W, BELL, N. H, ETTINGER, M. P, WALSH, B. W, FAVUS, M. J, MAKO, B, LIXIA WANG, SMITH, M. E, GORMLEY, G. J, MELTON, M. E

    “…This study compared the effects of oral alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. Women at least 5 yr…”
    Get full text
    Journal Article
  11. 11

    Invasive versus Conservative Strategies in unstable angina and non-Q-wave myocardial infarction following treatment with Tirofiban : Rationale and study design of the international TACTICS-TIMI 18 trial by CANNON, C. P, WEINTRAUB, W. S, DEMOPOULOS, L. A, ROBERTSON, D. H, GORMLEY, G. J, BRAUNWALD, E

    Published in The American journal of cardiology (15-09-1998)
    “…In treating unstable angina and non-ST-segment elevation myocardial infarction, there is considerable debate regarding the use of an invasive strategy versus…”
    Get full text
    Journal Article
  12. 12

    Long-term effects of finasteride on prostate tissue composition by Marks, Leonard S., Partin, Alan W., Dorey, Frederick J., Gormley, Glenn J., Epstein, Jonathan I., Garris, Joel B., Macairan, Maria Luz, Shery, Erlinda D., Santos, Paul Bryan, Stoner, Elizabeth, deKernion, Jean B.

    Published in Urology (Ridgewood, N.J.) (01-03-1999)
    “…Objectives. To determine the long-term effects of finasteride treatment on prostate tissue composition; to relate these effects to clinical outcomes; and to…”
    Get full text
    Journal Article
  13. 13

    Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma by Schenker, Howard, Maloney, Susan, Liss, Charles, Gormley, Glenn, Hartenbaum, David

    Published in Clinical therapeutics (1999)
    “…This study was designed to compare timolol maleate ophthalmic gel-forming solution 0.5% (timolol gel) once daily with timolol maleate ophthalmic solution 0.5%…”
    Get full text
    Journal Article
  14. 14

    The effect of finasteride on prostate specific antigen: review of available data by Guess, H A, Gormley, G J, Stoner, E, Oesterling, J E

    Published in The Journal of urology (01-01-1996)
    “…We reviewed the available data on the effect of finasteride on serum levels of prostate specific antigen (PSA), PSA velocity and PSA density in men with benign…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Chapter 41 - Modern Drug Discovery and Development by Salazar, Daniel E., Gormley, Glenn

    “…Drug discovery and development are among the most important translational science activities that contribute to human health and well-being. This chapter…”
    Get full text
    Book Chapter
  17. 17

    Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia by Pannek, J, Marks, L S, Pearson, J D, Rittenhouse, H G, Chan, D W, Shery, E D, Gormley, G J, Subong, E N, Kelley, C A, Stoner, E, Partin, A W

    Published in The Journal of urology (01-02-1998)
    “…Finasteride therapy for benign prostatic hyperplasia (BPH) results in a marked lowering of serum prostate specific antigen (PSA) levels. However, little is…”
    Get more information
    Journal Article
  18. 18

    Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia by Marks, L S, Partin, A W, Gormley, G J, Dorey, F J, Shery, E D, Garris, J B, Subong, E N, Stoner, E, deKernion, J B

    Published in The Journal of urology (01-06-1997)
    “…We sought to quantify prostate tissue changes induced by finasteride and to identify a predictor of finasteride response in men with symptomatic benign…”
    Get more information
    Journal Article
  19. 19
  20. 20